"Expanding Peptide Chemical Space via Acid-Mediated Arginine Modification"
Today, we are sharing a research article led by Monika Raj's team, published in Organic Letters. This study developed an acid-mediated, chemoselective method that efficiently converts the guanidino group of arginine in peptides into an amino pyrimidine structure using malonaldehyde (MDA). This strategy not only achieves near-quantitative conversion and excellent chemoselectivity but also enables further late-stage modification to construct imidazo[1,2-a]pyrimidinium salts, significantly enhancing the cell membrane permeability of peptides. It provides a new platform for expanding the chemical space of peptide-based drugs.
01 Research Background
Site-specific modification of peptides is a crucial strategy for expanding their chemical diversity and optimizing biological functions. However, most existing methods focus on highly reactive residues like lysine, cysteine, and tryptophan, while effective strategies for arginine – a key residue comprising about 5.8% of proteins – remain scarce. The guanidino group of arginine, with its high pKa (~12.5) and low nucleophilicity, makes its selective modification highly challenging. Current arginine labeling strategies based on 1,2-dicarbonyl compounds (e.g., phenylglyoxal) often produce complex mixtures, limiting their application (Scheme 1). Therefore, developing an efficient and highly selective method for arginine modification is of great significance for advancing peptide engineering and chemical biology research.
Scheme 1. Background and Reaction Development
02 Innovative Highlights
- Pioneering an acid-mediated selective arginine modification method: For the first time, utilizes the specific reaction between MDA and the arginine guanidino group under strong acid conditions (12 M HCl) to achieve efficient, near-quantitative (>99%) conversion to amino pyrimidine, overcoming the bottleneck of poor selectivity in traditional methods.
- Reversible side reaction clearance strategy: Innovatively introduces butylamine treatment to selectively reverse potential side products formed between MDA and other nucleophilic residues (e.g., tryptophan, lysine, histidine), ensuring the singularity and high purity of the final product.
- Function-oriented late-stage modification and performance enhancement: The generated amino pyrimidine peptides not only exhibit approximately 2-fold improved cell membrane permeability but also serve as a versatile handle for further reaction with 2-bromoacetophenone derivatives to construct pharmaceutically relevant imidazo[1,2-a]pyrimidinium salts, achieving a leap from simple "modification" to advanced "functionalization".
03 Results and Discussion
3.1 Reaction Condition Optimization and Chemoselectivity Validation
Starting with the reaction of model peptide Ac-RYF (1a) and MDA, the study systematically optimized the reaction conditions. Results indicated no product formation under mild neutral, basic, or weakly acidic buffer conditions, highlighting the necessity of a strong acid environment. The optimal conditions were determined as: 12 M HCl as solvent, 100 equivalents of MDA, room temperature, 1-hour reaction, achieving >99% conversion (Figure 1). These conditions demonstrated exceptional chemoselectivity; even in peptides containing other nucleophilic residues like tryptophan (1b), lysine (1c), and histidine (1d), MDA preferentially reacted with arginine. The small amount of minor side products formed could be effectively cleared by butylamine treatment, underscoring the robustness of the method (Figure 1).
Figure 1. Chemoselectivity study of MDA with peptides containing reactive amino acids including tryptophan, lysine, and histidine along with arginine.
3.2 Investigation of Substrate Scope
Under the optimal conditions, the method demonstrated broad substrate adaptability (Figure 2). A series of arginine-containing peptides (1f-1k) were efficiently converted to the corresponding amino pyrimidine derivatives (2f-2k) with conversion rates all >99%. Notably, a peptide containing two arginine residues (1k) underwent quantitative double-site modification (2k), proving the method's capability for handling complex peptide sequences.
Figure 2. Substrate scope of arginine-containing peptides 1f−1k to amino pyrimidine peptides 2f−2k.
3.3 Validation of Enhanced Cell Membrane Permeability
The cell membrane permeability of the peptides before and after modification was evaluated using the Cellular Chloroalkane Permeability Assay (CAPA) (Figure 3). Results showed that the modified peptides containing the amino pyrimidine structure (ct-2l, ct-2m) exhibited approximately 2-fold higher membrane permeability compared to their unmodified counterparts (ct-1l, ct-1m). This significant improvement is attributed to the amino pyrimidine ring modulating the positive charge distribution and increasing hydrophobicity, thereby favoring transmembrane transport.
Figure 3. CAPA assay of unmodified (ct-1l and ct-1m) and modified (ct-2l and ct-2m) peptides to determine their cell permeability.
3.4 Application in Late-Stage Functionalization
The study further demonstrated the extensibility of this platform (Figure 4). The arginine-derived amino pyrimidine peptide (2n) was reacted with various substituted 2-bromoacetophenone derivatives (3a-3d), successfully constructing a series of imidazo[1,2-a]pyrimidinium salts (4a-4d) in good yields (63-75%). Such fused heterocyclic systems are important pharmacophores, opening a new avenue for deep functionalization of peptides.
Figure 4. Late-stage functionalization of the amino pyrimidine arginine 2n with 2-bromoacetophenone derivatives 3.
04 Conclusion and Future Perspectives
This study successfully developed a novel, efficient, and highly selective acid-mediated strategy for arginine modification. Its core value lies in: 1) solving the long-standing challenge of selective arginine modification; 2) ensuring robustness through a reversible side-reaction clearance mechanism; and 3) generating amino pyrimidine peptides that possess both improved cell permeability and potential for further functionalization. This work not only provides a powerful tool for expanding the chemical space of peptides but also invigorates the development of next-generation peptide therapies by endowing peptide molecules with improved drug-like properties (e.g., membrane permeability). In the future, this strategy holds broad application prospects in areas such as live-cell labeling, targeted delivery system construction, and innovative drug discovery based on peptide-heterocycle chimeras.
Original Article:
Sihag P, Kwon M, Misra A, Raj M. Expanding Peptide Chemical Space via Acid-Mediated Arginine Modification. Org Lett. 2025 Oct 30.